Additionally, Tian et al. [73] demonstrated that administering CUR at a dose of 60 mg/kg to leptin-deficient (ob/ob) mice for 8 weeks increased GLP-1 levels, thereby enhancing energy expenditure and improving both obesity and glucose tolerance. This evidence concerns the gene GCG and obesity disorder.